$68.83
0.01% day before yesterday
Nasdaq, Sep 06, 10:03 pm CET
ISIN
US05465P1012
Symbol
AXNX

Axonics Modulation Technologies, Inc. Stock price

$68.83
+0.12 0.17% 1M
+1.28 1.89% 6M
+6.60 10.61% YTD
+10.64 18.28% 1Y
-8.38 10.85% 3Y
+33.12 92.75% 5Y
+53.85 359.48% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.01 0.01%
ISIN
US05465P1012
Symbol
AXNX
Sector

Key metrics

Market capitalization $3.52b
Enterprise Value $3.21b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 169.53
EV/Sales (TTM) EV/Sales 7.85
P/S ratio (TTM) P/S ratio 8.61
P/B ratio (TTM) P/B ratio 5.46
Revenue growth (TTM) Revenue growth 27.81%
Revenue (TTM) Revenue $408.81m
EBIT (operating result TTM) EBIT $-5.11m
Free Cash Flow (TTM) Free Cash Flow $18.92m
Cash position $343.41m
EPS (TTM) EPS $-0.03
P/E forward 250.29
P/S forward 7.81
EV/Sales forward 7.12
Short interest 7.26%
Show more

Is Axonics Modulation Technologies, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Axonics Modulation Technologies, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Axonics Modulation Technologies, Inc. forecast:

1x Buy
10%
9x Hold
90%

Analyst Opinions

10 Analysts have issued a Axonics Modulation Technologies, Inc. forecast:

Buy
10%
Hold
90%

Financial data from Axonics Modulation Technologies, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
409 409
28% 28%
100%
- Direct Costs 108 108
17% 17%
26%
301 301
32% 32%
74%
- Selling and Administrative Expenses 250 250
25% 25%
61%
- Research and Development Expense 42 42
26% 26%
10%
9.02 9.02
264% 264%
2%
- Depreciation and Amortization 14 14
11% 11%
3%
EBIT (Operating Income) EBIT -5.11 -5.11
72% 72%
-1%
Net Profit -1.71 -1.71
95% 95%
0%

In millions USD.

Don't miss a Thing! We will send you all news about Axonics Modulation Technologies, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Axonics Modulation Technologies, Inc. Stock News

Neutral
Business Wire
about one month ago
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results for the three months ended June 30, 2024. “Axonics continued to execute at a high level in the second quarter, generating record revenue and s...
Neutral
Business Wire
4 months ago
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics F15™ recharge-free sacral neuromodulation (SNM) system in Australia to treat adults with overactive bladder. “Approval of the Axonics recharge-free system is welcome news for Australians with bladder and ...
Neutral
Business Wire
4 months ago
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results for the three months ended March 31, 2024. “Our commercial team continued to execute at a high level in the first quarter, generating revenue growth of 29% ...
More Axonics Modulation Technologies, Inc. News

Company Profile

Axonics Modulation Technologies, Inc. operates as a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation solutions. The firm focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in March 2012 and is headquartered in Irvine, CA.

Head office United States
CEO Raymond Cohen
Employees 797
Founded 2012
Website www.axonics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today